About this FactMed analysis covering adverse side effect reports of PLASMA patients who developed AKINESIA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking PLASMA reported AKINESIA to the FDA. A total of 819 PLASMA drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between PLASMA and AKINESIA. In doing so, we compare PLASMA with other drugs that cause AKINESIA, to help you evaluate whether or not PLASMA causes AKINESIA. Likewise, this page shows the most highly-reported side effects of PLASMA, so you can see if AKINESIA ranks among PLASMA's most well-known side effects.
Summary Statistics
Reports of PLASMA causing AKINESIA: 1
Reports of any side effect of PLASMA : 819
Percentage of PLASMA patients where AKINESIA is a reported side effect: 0.1221%

FDA reports of any drug causing AKINESIA : 753
Average percentage for all medicated patients where AKINESIA is reported as a complication: 0.0047%

Physician opinion on PLASMA as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing PLASMA:
PRODUCT USED FOR UNKNOWN INDICATION ( 33 patients )
COAGULOPATHY ( 16 patients )
FACTOR VIII DEFICIENCY ( 11 patients )
OPERATIVE HAEMORRHAGE ( 6 patients )
ANAEMIA ( 5 patients )
DRUG USE FOR UNKNOWN INDICATION ( 5 patients )
CEREBRAL HAEMORRHAGE ( 5 patients )
DENTAL IMPLANTATION ( 4 patients )
ESCHERICHIA SEPSIS ( 4 patients )
HAEMOGLOBIN DECREASED ( 4 patients )
FACTOR IX DEFICIENCY ( 4 patients )
HAEMORRHAGE ( 4 patients )
HYPOALBUMINAEMIA ( 3 patients )
RENAL TRANSPLANT ( 3 patients )
CORONARY ARTERY BYPASS ( 3 patients )
INTERNATIONAL NORMALISED RATIO INCREASED ( 3 patients )
MYELODYSPLASTIC SYNDROME ( 2 patients )
POST PROCEDURAL HAEMORRHAGE ( 2 patients )
AORTIC SURGERY ( 2 patients )
HYPOVOLAEMIC SHOCK ( 2 patients )
CARDIOGENIC SHOCK ( 2 patients )
TRANSFUSION ( 2 patients )
HYPOVOLAEMIA ( 2 patients )
TRANSPLANT REJECTION ( 2 patients )
LIVER DISORDER ( 1 patients )
VASCULITIS ( 1 patients )
MULTIPLE MYELOMA ( 1 patients )
BLOOD FIBRINOGEN DECREASED ( 1 patients )
SUPPLEMENTATION THERAPY ( 1 patients )
INJURY ( 1 patients )
COAGULATION TEST ABNORMAL ( 1 patients )
INTERSTITIAL LUNG DISEASE ( 1 patients )
TRICUSPID VALVE REPAIR ( 1 patients )
LYMPHOMA ( 1 patients )
MULTIPLE SCLEROSIS ( 1 patients )
ACUTE MYELOID LEUKAEMIA ( 1 patients )
HAEMODIALYSIS ( 1 patients )
AORTIC DISSECTION ( 1 patients )
POSTPARTUM HAEMORRHAGE ( 1 patients )
AORTIC VALVE REPLACEMENT ( 1 patients )
PROTEIN TOTAL DECREASED ( 1 patients )
BLOOD PRODUCT TRANSFUSION ( 1 patients )
SHOCK HAEMORRHAGIC ( 1 patients )
ILL-DEFINED DISORDER ( 1 patients )
SURGERY ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with AKINESIA:

MODOPAR (292 patients)
EFFEXOR (145 patients)
XANAX (129 patients)
VIOXX (116 patients)
STALEVO 100 (111 patients)
ASPIRIN (73 patients)
PERGOLIDE MESYLATE (56 patients)
SINEMET (55 patients)
RISPERDAL (54 patients)
ATHYMIL (52 patients)
COMTAN (45 patients)
MADOPAR (41 patients)
LORAZEPAM (40 patients)
MADOPAR DISPERSIBLE (39 patients)
IMOVANE (38 patients)
ZYPREXA (37 patients)
ATARAX (37 patients)
VALPROATE SODIUM (36 patients)
CLOZAPINE (31 patients)
DEPAKOTE (30 patients)
CITALOPRAM HYDROBROMIDE (29 patients)
CLOBAZAM (29 patients)
FUROSEMIDE (28 patients)
REQUIP (28 patients)
PARLODEL (27 patients)
EXELON (27 patients)
PAXIL (26 patients)
DIGOXIN (25 patients)
LASIX (25 patients)
ERYTHROMYCIN (25 patients)
SEROQUEL (25 patients)
LAMOTRIGINE (25 patients)
RISPERIDONE (24 patients)
GENTAMICIN (24 patients)
PHENYTOIN (23 patients)
AMANTADINE HCL (23 patients)
ACETAMINOPHEN (21 patients)
HALDOL (21 patients)
DIAZEPAM (20 patients)
VALTREX (20 patients)
OMEPRAZOLE (19 patients)
PAROXETINE HCL (19 patients)
ACETAMINOPHEN AND TRAMADOL HCL (18 patients)
CEFOTAXIME (18 patients)
SPIRONOLACTONE (18 patients)
LEVOTHYROXINE SODIUM (18 patients)
TEGRETOL (17 patients)
PREDNISOLONE (17 patients)
DEPAKENE (17 patients)
HALOPERIDOL (17 patients)
SIMVASTATIN (16 patients)
NITROGLYCERIN (16 patients)
ZOLOFT (15 patients)
PIPERACILLIN (15 patients)
LIPITOR (15 patients)
LEXOMIL (14 patients)
CLOPIDOGREL (14 patients)
OLANZAPINE (14 patients)
CABERGOLINE (14 patients)
TEMESTA (14 patients)
CLONAZEPAM (14 patients)
IBUPROFEN (14 patients)
NEURONTIN (13 patients)
LEVODOPA (13 patients)
WARFARIN SODIUM (13 patients)
SERENACE (13 patients)
OXYCONTIN (13 patients)
MEMANTINE HCL (13 patients)
ATENOLOL (13 patients)
DIOVAN (12 patients)
HIZENTRA (12 patients)
PRAMIPEXOLE DIHYDROCHLORIDE (12 patients)
ALBUTEROL (12 patients)
CELEBREX (12 patients)
HEPARIN (12 patients)
SEROQUEL XR (12 patients)
ENOXAPARIN SODIUM (12 patients)
ATORVASTATIN CALCIUM (12 patients)
ABILIFY (11 patients)
PLAVIX (11 patients)
FLUOXETINE (11 patients)
LOXAPINE HCL (11 patients)
COREG (11 patients)
TAXOTERE (11 patients)
GLEEVEC (11 patients)
VENLAFAXINE (11 patients)
PREVACID (11 patients)
CAPTOPRIL (11 patients)
CIPRO (11 patients)
CYCLOSPORINE (11 patients)
LANTUS (10 patients)
SYNTHROID (10 patients)
ACTONEL (10 patients)
MIRAPEX (10 patients)
KETOCONAZOLE (10 patients)
ANTIBIOTICS (10 patients)
ARICEPT (10 patients)
HEPARIN SODIUM INJECTION (10 patients)
AVONEX (10 patients)
RAMIPRIL (9 patients)
INSULIN (9 patients)
NECYRANE (9 patients)
MORPHINE (9 patients)
FERROUS SULFATE TAB (9 patients)
PRAZEPAM (9 patients)
DONEPEZIL HCL (9 patients)
CARBOCISTEINE (9 patients)
EXTAVIA (9 patients)
BROMOCRIPTINE MESYLATE (9 patients)
AMBIEN (9 patients)
AMOXICILLIN (9 patients)
RISPERDAL CONSTA (9 patients)
LAMICTAL (9 patients)
SINGULAIR (9 patients)
ECONAZOLE NITRATE (9 patients)
ARTANE (9 patients)
FOLIC ACID (9 patients)
PRAMIPEXOLE DIHYCHLLORIDE (9 patients)
LISINOPRIL (9 patients)
CEFUROXIME (9 patients)
LYSOPAINE (9 patients)
PRILOSEC (9 patients)
HYDROCHLOROTHIAZIDE (9 patients)
SANDIMMUNE (9 patients)
CYMBALTA (8 patients)
ELUDRIL (8 patients)
MIRTAZAPINE (8 patients)
SOLANAX (8 patients)
EPINEPHRINE (8 patients)
TYLENOL (CAPLET) (8 patients)
CIATYL Z (8 patients)
TRAMAL (8 patients)
AMIODARONE HCL (8 patients)
COUMADIN (8 patients)
NEUROCIL (8 patients)
OXAZEPAM (8 patients)
LEVEMIR (8 patients)
AVANDIA (8 patients)
NEXIUM (8 patients)
PROTONIX (8 patients)
ZOCOR (8 patients)
WELLBUTRIN (8 patients)
BIPERIDEN HYDROCHLORIDE TAB (8 patients)
METFORMIN HCL (7 patients)
NORVASC (7 patients)
METOPROLOL (7 patients)
TRIVASTAL (7 patients)
ZANAFLEX (7 patients)
HUMIRA (7 patients)
ALDACTONE (7 patients)
SOLU-CORTEF (7 patients)
ALLOPURINOL (7 patients)
TRIHEXYPHENIDYL HCL (7 patients)
PREVISCAN (7 patients)
DOPAMINE HCL (7 patients)
SERTRALINE HCL (7 patients)
THIOPENTAL SODIUM (7 patients)
ENALAPRIL MALEATE (7 patients)
BISOPROLOL FUMARATE (7 patients)
TRAZODONE HCL (7 patients)
LITHIUM CARBONATE (7 patients)
TYLENOL (7 patients)
TRANXENE (7 patients)
POTASSIUM CHLORIDE (7 patients)
CEFOTAXIME SODIUM (7 patients)
PREDONINE (7 patients)
ISOSORBIDE DINITRATE (7 patients)
CYTARABINE (7 patients)
VITAMIN D (7 patients)
CARBIDOPA AND LEVODOPA (6 patients)
LOVENOX (6 patients)
ACETYLSALICYLIC ACID SRT (6 patients)
ESCITALOPRAM (6 patients)
DEXAMETHASONE TAB (6 patients)
SERTRALINE HYDROCHLORIDE (6 patients)
EVEROLIMUS (6 patients)
TASMAR (6 patients)
ALPRAZOLAM (6 patients)
MANTADIX (6 patients)
PRAZINE (6 patients)
HERCEPTIN (6 patients)
DEROXAT (6 patients)
AMLODIPINE (6 patients)
METHYLPREDNISOLONE (6 patients)
PURSENNID (6 patients)
REMICADE (6 patients)
SILECE (6 patients)
ZOVIRAX (6 patients)
MYCOPHENOLATE MOFETIL (6 patients)
ARAVA (6 patients)
LEPTICUR (6 patients)
CARBAMAZEPINE (6 patients)
TOBRAMYCIN (6 patients)
SYMMETREL (6 patients)
ATIVAN (6 patients)
ATORVASTATIN (6 patients)
CIPRALEX (ESCITALOPRAM) (6 patients)
LYRICA (6 patients)
CLARITHROMYCIN (6 patients)
CITALOPRAM (6 patients)
VANCOMYCIN (6 patients)
HEPTAMINOL (6 patients)
AZILECT (6 patients)
HUMALOG (6 patients)
PREDNISONE TAB (6 patients)
PROPRANOLOL (6 patients)
PROCTOLOG (6 patients)
INTETRIX (6 patients)
RANITIDINE (6 patients)
MS CONTIN (5 patients)
Most common side effects for patients taking PLASMA:
RENAL FAILURE (361 patients)
PAIN (355 patients)
INJURY (327 patients)
UNEVALUABLE EVENT (324 patients)
ANXIETY (311 patients)
FEAR (294 patients)
RENAL INJURY (253 patients)
EMOTIONAL DISTRESS (243 patients)
RENAL IMPAIRMENT (225 patients)
ANHEDONIA (215 patients)
STRESS (215 patients)
DEATH (186 patients)
MULTI-ORGAN FAILURE (182 patients)
DEPRESSION (104 patients)
HEPATITIS C VIRUS (86 patients)
RENAL FAILURE ACUTE (82 patients)
CEREBROVASCULAR ACCIDENT (57 patients)
HEPATITIS C (34 patients)
MYOCARDIAL INFARCTION (30 patients)
HEPATITIS B VIRUS (29 patients)
RESPIRATORY FAILURE (27 patients)
PNEUMONIA (27 patients)
CARDIAC ARREST (22 patients)
PULMONARY OEDEMA (20 patients)
GASTROINTESTINAL HAEMORRHAGE (20 patients)
PSYCHIATRIC SYMPTOM (18 patients)
HEPATIC ENCEPHALOPATHY (18 patients)
HEPATITIS B (17 patients)
HYPOTENSION (17 patients)
NERVOUSNESS (17 patients)
LIVER FUNCTION TEST ABNORMAL (16 patients)
THROMBOCYTOPENIA (16 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (15 patients)
ADVERSE EVENT (15 patients)
HIV INFECTION (15 patients)
PLATELET COUNT DECREASED (15 patients)
ANAEMIA (14 patients)
CARDIAC DISORDER (14 patients)
FEAR OF DEATH (14 patients)
ACUTE HEPATIC FAILURE (13 patients)
PHARMACEUTICAL PRODUCT COMPLAINT (13 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (13 patients)
SEPSIS (13 patients)
CARDIOGENIC SHOCK (13 patients)
SHOCK (13 patients)
ALANINE AMINOTRANSFERASE INCREASED (12 patients)
TRANSFUSION-RELATED ACUTE LUNG INJURY (11 patients)
HAEMORRHAGE (11 patients)
HEPATIC FAILURE (11 patients)
CARDIAC FAILURE (11 patients)
EMOTIONAL DISORDER (11 patients)
WHITE BLOOD CELL COUNT INCREASED (11 patients)
ORGAN FAILURE (11 patients)
CONDITION AGGRAVATED (11 patients)
CYTOMEGALOVIRUS INFECTION (11 patients)
PANCYTOPENIA (10 patients)
PYREXIA (10 patients)
DRUG INEFFECTIVE (10 patients)
ASTHENIA (10 patients)
BLOOD CREATININE INCREASED (10 patients)
COMA HEPATIC (10 patients)
ANAPHYLACTIC REACTION (9 patients)
INFECTION (9 patients)
DIARRHOEA (9 patients)
DISABILITY (9 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (9 patients)
PULMONARY EMBOLISM (8 patients)
ACUTE PULMONARY OEDEMA (8 patients)
HAEMOGLOBIN DECREASED (8 patients)
HEPATIC INFECTION FUNGAL (8 patients)
DYSPNOEA (8 patients)
COAGULOPATHY (8 patients)
HEPATITIS (8 patients)
HAEMATOMA (7 patients)
ACUTE MYOCARDIAL INFARCTION (7 patients)
HYPERTENSIVE CRISIS (7 patients)
MUCOSAL INFLAMMATION (7 patients)
BLOOD LACTATE DEHYDROGENASE INCREASED (7 patients)
ILEUS (7 patients)
BRONCHOPULMONARY ASPERGILLOSIS (7 patients)
RESPIRATORY DISTRESS (7 patients)
ENTEROCOCCAL SEPSIS (7 patients)
FALL (7 patients)
FEBRILE NEUTROPENIA (7 patients)
HAEMORRHAGIC DIATHESIS (7 patients)
CONVULSION (7 patients)
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY (6 patients)
METABOLIC DISORDER (6 patients)
ATRIAL FIBRILLATION (6 patients)
DRUG HYPERSENSITIVITY (6 patients)
POST PROCEDURAL COMPLICATION (6 patients)
BLOOD PRESSURE INCREASED (6 patients)
HYPOXIA (6 patients)
CANDIDIASIS (6 patients)
STAPHYLOCOCCAL INFECTION (6 patients)
EPISTAXIS (6 patients)
THROMBOSIS (6 patients)
MENTAL DISORDER (6 patients)
NEUROPATHY PERIPHERAL (6 patients)
CONCOMITANT DISEASE PROGRESSION (6 patients)
PATENT DUCTUS ARTERIOSUS (6 patients)
MALNUTRITION (5 patients)
DYSPHAGIA (5 patients)
VOMITING (5 patients)
DRUG INTERACTION (5 patients)
AMNESIA (5 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (5 patients)
NEUTROPENIA (5 patients)
HERPES VIRUS INFECTION (5 patients)
RENAL DISORDER (5 patients)
SEPTIC SHOCK (5 patients)
SPUTUM CULTURE POSITIVE (5 patients)
STREPTOCOCCAL INFECTION (5 patients)
TUMOUR LYSIS SYNDROME (5 patients)
TACHYARRHYTHMIA (5 patients)
VENTRICULAR ARRHYTHMIA (5 patients)
OEDEMA PERIPHERAL (5 patients)
DRUG EXPOSURE DURING PREGNANCY (5 patients)
HEPATITIS C ANTIBODY POSITIVE (5 patients)
PULMONARY HAEMORRHAGE (5 patients)
BRADYCARDIA (5 patients)
RENAL FAILURE CHRONIC (5 patients)
C-REACTIVE PROTEIN INCREASED (5 patients)
ECCHYMOSIS (5 patients)
INTERNATIONAL NORMALISED RATIO INCREASED (5 patients)
THROMBOSIS IN DEVICE (5 patients)
CARDIOVASCULAR INSUFFICIENCY (5 patients)
CEREBRAL HAEMORRHAGE (5 patients)
CEREBRAL INFARCTION (5 patients)
ERYTHEMA (5 patients)
FATIGUE (5 patients)
SOMNOLENCE (5 patients)
NAUSEA (5 patients)
NEONATAL DISORDER (5 patients)
HEADACHE (5 patients)
SHOCK HAEMORRHAGIC (5 patients)
INTRAVENTRICULAR HAEMORRHAGE NEONATAL (5 patients)
DISEASE PROGRESSION (5 patients)
ABSCESS (4 patients)
ACIDOSIS (4 patients)
ACUTE GRAFT VERSUS HOST DISEASE (4 patients)
ACUTE RESPIRATORY FAILURE (4 patients)
OXYGEN SATURATION DECREASED (4 patients)
LEUKAEMIA PLASMACYTIC (4 patients)
ANAPHYLACTIC SHOCK (4 patients)
VENOUS THROMBOSIS LIMB (4 patients)
JUGULAR VEIN THROMBOSIS (4 patients)
HYPERTENSION (4 patients)
HIV TEST POSITIVE (4 patients)
APHTHOUS STOMATITIS (4 patients)
PULMONARY HYPERTENSION (4 patients)
ASCITES (4 patients)
TRYPTASE INCREASED (4 patients)
TRANSMISSION OF AN INFECTIOUS AGENT VIA A MEDICINAL PRODUCT (4 patients)
WHITE BLOOD CELL COUNT DECREASED (4 patients)
BLOOD ALKALINE PHOSPHATASE INCREASED (4 patients)
OLIGURIA (4 patients)
HYPERHIDROSIS (4 patients)
BLOOD URIC ACID INCREASED (4 patients)
HYPOGLYCAEMIA NEONATAL (4 patients)
CARDIAC FAILURE ACUTE (4 patients)
CARDIAC FAILURE CONGESTIVE (4 patients)
INCISION SITE INFECTION (4 patients)
UNRESPONSIVE TO STIMULI (4 patients)
LOSS OF CONSCIOUSNESS (4 patients)
OEDEMA (4 patients)
COGNITIVE DISORDER (4 patients)
COMA (4 patients)
COUGH (4 patients)
MUSCLE HAEMORRHAGE (4 patients)
PLEURISY (4 patients)
DERMATITIS EXFOLIATIVE (4 patients)
PETECHIAE (4 patients)
PNEUMOCYSTIS JIROVECI PNEUMONIA (3 patients)
ABDOMINAL PAIN (3 patients)
ACTIVITIES OF DAILY LIVING IMPAIRED (3 patients)
HEPARIN-INDUCED THROMBOCYTOPENIA (3 patients)
MULTIPLE MYELOMA (3 patients)
AORTIC DISSECTION (3 patients)
RESPIRATORY ARREST (3 patients)
HAEMODIALYSIS (3 patients)
GASTROINTESTINAL DISORDER (3 patients)
HEART RATE INCREASED (3 patients)
BLOOD CALCIUM DECREASED (3 patients)
PALLOR (3 patients)
HAEMOLYTIC URAEMIC SYNDROME (3 patients)
GAIT DISTURBANCE (3 patients)
PLEURAL EFFUSION (3 patients)
BLOOD UREA INCREASED (3 patients)
BODY TEMPERATURE INCREASED (3 patients)
BONE MARROW DEPRESSION (3 patients)
HYPOALBUMINAEMIA (3 patients)
HAEMATURIA (3 patients)
HAEMATOCRIT DECREASED (3 patients)
COLITIS ISCHAEMIC (3 patients)
COLLAPSE OF LUNG (3 patients)
HEPATIC ENZYME INCREASED (3 patients)
OFF LABEL USE (3 patients)
CONTINUOUS HAEMODIAFILTRATION (3 patients)
CORONARY ARTERY THROMBOSIS (3 patients)
HAEMOLYSIS (3 patients)
CYTOMEGALOVIRUS TEST POSITIVE (3 patients)
HEPATOTOXICITY (3 patients)
PANCREATITIS (3 patients)
PLASMAPHERESIS (3 patients)
HEPATITIS FULMINANT (3 patients)
HISTIOCYTOSIS HAEMATOPHAGIC (3 patients)
DIABETES MELLITUS (3 patients)
PRODUCT QUALITY ISSUE (3 patients)
HERPES ZOSTER (3 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for PLASMA


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about AKINESIA and PLASMA, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question: